Results 161 to 170 of about 13,035,802 (272)

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Conclusiones. Esto recién empieza...

Telondefondo : Revista de Teoría y Crítica Teatral, 2018
UBACyT Los trabajadores del espectáculo en Buenos Aires: la especificidad laboral...
doaj   +1 more source

[How to detect scientific texts generated with artificial intelligence?] [PDF]

Rev Med Inst Mex Seguro Soc
Chávez-Martínez O.
europepmc   +1 more source

Conclusiones del Bloque I [PDF]

, 2019
Valle López, Javier M.
core   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Utilidad del PSA en vesículas extracelulares como biomarcador de seguimiento en el cáncer de próstata. [PDF]

Adv Lab Med
Sandúa A, Pérez-Gracia JL, Alegre E, González Á.   +3 more
europepmc   +1 more source

General conclusions of the 2 nd Cielo World Congress “Fourth industrial revolution and globalization: protecting the employment, health and private life of workers in the face of challenges ahead" [PDF]

, 2018
Sierra Benítez, Esperanza Macarena
core  

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Conclusiones: XI Congreso Nacional de Atención Farmacéutica (Cádiz 2019)

Pharmaceutical Care España, 2019
Alberto Virues
doaj   +2 more sources

Comunicaciones LX Reunión Anual SENFC Barcelona, 2 a 4 de octubre de 2024. [PDF]

Rev Neurol
europepmc   +1 more source